Cargando…

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

BACKGROUND: Mucin 1 antigen, highly expressed by epithelial ovarian cancer (EOC), is a potential target for immunotherapy. A previous successful phase 1 trial was conducted in patients with adenocarcinoma who were injected with Cvac, autologous monocyte-derived dendritic cells (DCs) incubated with m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Paul LR, Quinn, Michael A, Grant, Peter T, Allen, David G, Jobling, Thomas W, White, Shane C, Zhao, Anne, Karanikas, Vaios, Vaughan, Hilary, Pietersz, Geoffrey, McKenzie, Ian FC, Gargosky, Sharron E, Loveland, Bruce E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080759/ https://www.ncbi.nlm.nih.gov/pubmed/24995129 http://dx.doi.org/10.1186/2051-1426-2-16

Ejemplares similares

Trial evaluating overall survival in epithelial ovarian cancer (eoc) patients in second remission with an autologous dendritic cell therapy targeting mucin 1
por: Gargosky, Sharron, et al.
Publicado: (2014)

Dendritic cell immunotherapy: clinical outcomes
por: Apostolopoulos, Vasso, et al.
Publicado: (2014)

Study of autologous dendritic cell therapy targeting Mucin 1 as a treatment for the maintenance of ovarian cancer patients in remission
por: Goh, J, et al.
Publicado: (2013)

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]
por: Apostolopoulos, Vasso, et al.
Publicado: (2006)

The Role of T Lymphocytes in Cancer Patients Undergoing Immunotherapy with Autologous Dendritic Cells
por: Rodrigues, Cláudia M., et al.
Publicado: (2011)

The in vitro and in vivo anti-tumour activity of N-AcMEL-(Fab')2 conjugates.
por: Smyth, M. J., et al.
Publicado: (1987)

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
por: Gray, H. J., et al.
Publicado: (2016)

Influence of Immunotherapy with Autologous Dendritic Cells on Innate and Adaptive Immune Response in Cancer
por: Matias, Bruna F., et al.
Publicado: (2013)

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
por: Bell, G M, et al.
Publicado: (2017)

Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
por: Bernal-Estévez, David A., et al.
Publicado: (2021)

Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
por: Jan, Chia-Ing, et al.
Publicado: (2018)

Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis
por: Liu, Haikun, et al.
Publicado: (2022)

Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes
por: Kontani, K, et al.
Publicado: (2001)

Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides
por: Brooks, Nicole, et al.
Publicado: (2015)

Examining attrition rates at one specialty addiction treatment provider in the United States: a case study using a retrospective chart review
por: Loveland, David, et al.
Publicado: (2014)

QS3: CRISPR/Cas9 Editing of Autologous Dendritic Cells to Enhance Angiogenesis and Wound Healing
por: Henn, Dominic, et al.
Publicado: (2021)

Novel strategy for manufacturing autologous dendritic cell/allogeneic tumor lysate vaccines for glioblastoma
por: Parney, Ian F, et al.
Publicado: (2020)

Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
por: Dillman, Robert O., et al.
Publicado: (2023)

Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice
por: Dieker, Jürgen, et al.
Publicado: (2015)

Clinicopathologic and Histopathologic Renal Abnormalities in Dogs with Coccidioidomycosis
por: Mehrkens, L.R., et al.
Publicado: (2016)

Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
por: Stacker, S. A., et al.
Publicado: (1989)

Armed conflict and mental health in Colombia
por: Tamayo-Agudelo, William, et al.
Publicado: (2019)

Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope
por: Brooks, Nicole, et al.
Publicado: (2018)

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells
por: Aghanejad, Ayuob, et al.
Publicado: (2018)

Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner
por: Melo-Gonzalez, Felipe, et al.
Publicado: (2018)

SIgA Binding to Mucosal Surfaces Is Mediated by Mucin-Mucin Interactions
por: Gibbins, Hannah L., et al.
Publicado: (2015)

Immunotherapy of Malignant Melanoma with Tumor Lysate-Pulsed Autologous Monocyte-Derived Dendritic Cells
por: Kim, Dae Suk, et al.
Publicado: (2011)

FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy
por: Fiammenghi, Laura, et al.
Publicado: (2010)

The Mechanisms of Human Renal Epithelial Cell Modulation of Autologous Dendritic Cell Phenotype and Function
por: Sampangi, Sandeep, et al.
Publicado: (2015)

Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: a prospective case series
por: Bobba, Samantha, et al.
Publicado: (2015)

Mucin
Publicado: (1905)

Phase I trial of active specific immunotherapy with autologous dendritic cells pulsed with autologous irradiated tumor stem cells in hepatitis B‐positive patients with hepatocellular carcinoma
por: Wang, Xiaojin, et al.
Publicado: (2015)

Automatic Determination of Secondary Dendrite Arm Spacing in AlSi-Cast Microstructures
por: Gawert, Christian, et al.
Publicado: (2021)

Synthesis of a Tetrahedral Metal–Organic Supramolecular Cage with Dendritic Carbazole Arms
por: Lianglu, Juanzi, et al.
Publicado: (2022)

Function of the CysD domain of the gel-forming MUC2 mucin
por: Ambort, Daniel, et al.
Publicado: (2011)

Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung
por: Proudfoot, Owen, et al.
Publicado: (2015)

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines
por: de Gruijl, Tanja D., et al.
Publicado: (2008)

Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
por: Giannoukakis, Nick, et al.
Publicado: (2011)

Modulation of HIV-1 replication in primary dendritic cells in contact with autologous CD4 T-lymphocytes
por: Su, B, et al.
Publicado: (2012)

Divergent Autologous T Cell Responses to Leukaemic Dendritic Cells during Remission in Acute Promyelocytic Leukaemia
por: Westers, Theresia M., et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8nsvlcp86pcu407bpmhs9nqeg5